BNP Paribas Asset Management
NUVB icon

BNP Paribas Asset Management’s Nuvation Bio NUVB Stock Holding History

BNP Paribas Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8K Sell
4,197
-174
-4% -$850 ﹤0.01% 2000
2026
Q1 		$18.8K Buy
4,371
+1,043
+31% +$5.81K ﹤0.01% 2057
2025
Q4 		$30K Buy
3,328
+1,264
+61% +$7.83K ﹤0.01% 1824
2025
Q3 		$8K Sell
2,064
-272
-12% -$741 ﹤0.01% 1703
2025
Q2 		$5K Buy
+2,336
New +$4.87K ﹤0.01% 2029

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BNP Paribas Asset Management's NUVB Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Nuvation Bio (NUVB) stake by 4% in Q2 2026, selling an estimated $850 and leaving 4,197 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

BNP Paribas Asset Management first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $30K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • BNP Paribas Asset Management held 4,197 shares of Nuvation Bio worth $23.8K as of Q2 2026.
  • BNP Paribas Asset Management sold 174 Nuvation Bio shares in Q2 2026, an estimated $850.
  • Nuvation Bio made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2000 holding.
  • BNP Paribas Asset Management first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Nuvation Bio position peaked at $30K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.